New insights in Merkel cell biology and treatment
18 May 2017
New insights in Merkel cell biology and treatment
Duration of checkpoint inhibitor therapy
Deregulated TGF-β superfamily signalling in cancer
Functions of BRCA1 and the implications for treatment
Genetic determinants of breast cancer immune phenotypes
IMPAKT conference highlights
Resistance to CDK4/6 inhibitors
Deciphering the connection of genetics, immune infiltration and prognosis
Genetic vs immune strategies in breast cancer
Transforming patient care through translational research
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial
Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity